Thrombosis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:23:26 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Thrombosis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis. https://clinicaltrials.eu/trial/a-study-to-compare-the-absorption-of-apixaban-capsules-and-apixaban-tablets-in-healthy-volunteers-to-prevent-thrombosis/ Thu, 30 Apr 2026 13:08:50 +0000 https://clinicaltrials.eu/trial/a-study-to-compare-the-absorption-of-apixaban-capsules-and-apixaban-tablets-in-healthy-volunteers-to-prevent-thrombosis/ This study focuses on thrombosis, which is a condition where a blood clot forms inside a blood vessel. The research involves comparing two different versions of the medication apixaban. One version is provided as Eliquis 5 mg film-coated tablets, while the other version is provided as apixaban 5 mg hard capsules. The goal of the study is to demonstrate the bioequivalence, meaning how the two different forms of the medicine perform similarly in the body, to ensure they work in the same way.

The study is conducted using a crossover design, which means participants receive both types of medication at different times during the trial. Participants will take a single oral dose, meaning the medicine is swallowed by mouth, while in a fasting state, which means not eating for a specific period before taking the medication. This process allows for a direct comparison of how the body absorbs the drug in its capsule form versus its tablet form.

]]> Study on the Effect of Tinzaparin Sodium on Survival in Patients with Advanced Pancreatic Cancer https://clinicaltrials.eu/trial/study-on-the-effect-of-tinzaparin-sodium-on-survival-in-patients-with-advanced-pancreatic-cancer/ Wed, 29 Apr 2026 15:03:00 +0000 https://clinicaltrials.eu/trial/study-on-the-effect-of-tinzaparin-sodium-on-survival-in-patients-with-advanced-pancreatic-cancer/ This clinical trial is focused on studying the effects of a treatment called tinzaparin sodium on patients with advanced pancreatic cancer. Pancreatic cancer is a serious condition where cancer cells form in the tissues of the pancreas, an organ that helps with digestion and blood sugar regulation. The treatment being tested is a type of medication known as a low molecular weight heparin, which is used to prevent blood clots. The study aims to see if using tinzaparin sodium can help improve the time patients live without their cancer getting worse, known as progression-free survival.

Participants in the study will receive tinzaparin sodium through injections. The study will compare the outcomes of patients receiving this treatment with those who do not, to understand its effectiveness in preventing blood clots during cancer treatment. The study will also monitor any side effects, such as bleeding, and assess the overall survival of patients receiving the treatment. The goal is to determine if tinzaparin sodium can be a beneficial addition to the standard chemotherapy regimen for pancreatic cancer.

The study will take place over a period of time, with regular check-ups to monitor the health and progress of the participants. The results will help researchers understand if tinzaparin sodium can improve the quality of life and survival rates for patients with advanced pancreatic cancer. This research is important for developing better treatment strategies for this challenging disease.

]]>